[{"id":"a744dd9f-e4be-4b72-a2de-da79e8056978","acronym":"","url":"https://clinicaltrials.gov/study/NCT05800964","created_at":"2023-04-06T14:03:12.774Z","updated_at":"2025-02-25T13:55:05.180Z","phase":"Phase 1","brief_title":"Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors","source_id_and_acronym":"NCT05800964","lead_sponsor":"Amgen","biomarkers":" MSLN • CDH3","pipe":"","alterations":" ","tags":["MSLN • CDH3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AMG 305"],"overall_status":"Recruiting","enrollment":" Enrollment 220","initiation":"Initiation: 06/13/2023","start_date":" 06/13/2023","primary_txt":" Primary completion: 06/10/2027","primary_completion_date":" 06/10/2027","study_txt":" Completion: 02/12/2028","study_completion_date":" 02/12/2028","last_update_posted":"2025-02-20"}]